Status | Study |
RECRUITING |
Study Name: A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides Condition: Cutaneous T-cell Lymphoma Date: 2022-03-16 Interventions: Orally every day starting at the dose of 150 mg/day flat dose.At Day 15, if the treatment is tolerated, patients will escalate the dose of |
Recruiting |
Study Name: Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma Condition: Peripheral T-cell Lymphoma Cutaneous T-cell Lymphoma Date: 2016-02-04 Interventions: Drug: E7777 |
Not yet recruiting |
Study Name: A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma Condition: Cutaneous T-cell Lymphoma (CTCL) Date: 2015-11-24 Interventions: Drug: Romidepsin Romidepsin at |
Recruiting |
Study Name: Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) Condition: Cutaneous T-Cell Lymphoma Date: 2015-10-29 Interventions: Biological: IPH4102 |
Recruiting |
Study Name: Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) Condition: Cutaneous T Cell Lymphoma Date: 2015-09-06 Interventions: Drug: dimethylfumarate dose escalation from 30 mg/d to 720 mg/d over 9 weeks following a preset design i |
Recruiting |
Study Name: FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Condition: Cutaneous T-Cell Lymphoma Date: 2015-05-13 Interventions: Drug: SGX301 (synthetic hypericin) |
Active, not recruiting |
Study Name: Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma Condition: Cutaneous T-Cell Lymphoma (CTCL) Date: 2014-08-06 Interventions: Drug: SHAPE topical gel Other Name: SHP-141 |
Recruiting |
Study Name: Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) Condition: Cutaneous T Cell Lymphoma Date: 2014-07-10 Interventions: Drug: Micro needle array-Doxorubicin (MNA-D) MNA-D patches will be applied to 3-4 CTCL skin patches or p |
Recruiting |
Study Name: Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma Condition: Cutaneous T-cell Lymphoma Date: 2014-02-11 Interventions: Drug: Romidepsin Other Names: |
Withdrawn |
Study Name: Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) Condition: Cutaneous T-cell Lymphoma (CTCL) Date: 2013-04-24 Interventions: Drug: Sirolimus 0.1% Ointment Sirolimus 0.1% ointment will be applied topically to all affected areas of |